IllnessIchthyosis + related dyskeratinoses, differential diagnosis
Summary
Comprehensive differential diagnostic panel for Ichthyosis + related diseases of disturbed keratinization comprising 59 guideline-curated genes and altogether 88 curated genes according to the clinical signs
135,1 kb (Extended panel: incl. additional genes)
- EDTA-anticoagulated blood (3-5 ml)
NGS +
[[Sanger]]
Gene panel
Selected genes
Name | Exon Length (bp) | OMIM-G | Referenz-Seq. | Heredity |
---|---|---|---|---|
ABCA12 | 6834 | NM_015657.4 | AR | |
ABHD5 | 1050 | NM_016006.6 | AR | |
ALDH3A2 | 1458 | NM_000382.3 | AR | |
ALOX12B | 2106 | NM_001139.3 | AR | |
ALOXE3 | 2532 | NM_021628.3 | AR | |
AP1S1 | 477 | NM_001283.5 | AR | |
CASP14 | 809 | NM_012114.3 | AR | |
CDSN | 1590 | NM_001264.5 | AD, AR | |
CERS3 | 1152 | NM_178842.5 | AR | |
CYP4F22 | 1596 | NM_173483.4 | AR | |
EBP | 693 | NM_006579.3 | XL | |
ERCC2 | 2283 | NM_000400.4 | AR | |
ERCC3 | 2349 | NM_000122.2 | AR | |
FLG | 12186 | NM_002016.2 | AD, AR | |
GBA1 | 1611 | NM_001005741.3 | AR | |
GJB2 | 681 | NM_004004.6 | AD | |
GJB3 | 813 | NM_024009.3 | AD, AR | |
GJB4 | 801 | NM_153212.3 | AD | |
GJB6 | 786 | NM_006783.5 | AD, digenisch | |
GTF2H5 | 216 | NM_207118.3 | AR | |
KRT1 | 1935 | NM_006121.4 | AD | |
KRT10 | 1755 | NM_000421.5 | AD | |
KRT2 | 1920 | NM_000423.3 | AD | |
LIPN | 1197 | NM_001102469.2 | AR | |
LORICRIN | 939 | NM_000427.3 | AD | |
MBTPS2 | 1560 | NM_015884.4 | XLR | |
MPLKIP | 540 | NM_138701.4 | AR | |
NIPAL4 | 1401 | NM_001099287.2 | AR | |
PHYH | 1017 | NM_006214.4 | AR | |
PNPLA1 | 1341 | NM_001145716.2 | AR | |
POMP | 426 | NM_015932.6 | AR | |
SNAP29 | 777 | NM_004782.4 | AR | |
SPINK5 | 3285 | NM_001127698.2 | AR | |
ST14 | 2568 | NM_021978.4 | AR | |
STS | 1752 | NM_000351.7 | XL | |
SUMF1 | 1125 | NM_182760.4 | AR | |
TGM1 | 2454 | NM_000359.3 | AR | |
VPS33B | 1854 | NM_018668.5 | AR | |
AAGAB | 621 | NM_001271885.2 | AD | |
AQP5 | 798 | NM_001651.4 | AD | |
CARD14 | 2223 | NM_001257970.1 | AD | |
CAST | 2253 | NM_001042440.5 | AR | |
CLDN1 | 636 | NM_021101.5 | AR | |
CLDN10 | 1038 | NM_001160100.2 | AR | |
CSTA | 297 | NM_005213.4 | AR | |
DOLK | 1617 | NM_014908.4 | AR | |
DSC2 | 2706 | NM_024422.6 | AR | |
DSG1 | 3150 | NM_001942.4 | AD, AR | |
DSP | 8616 | NM_004415.4 | AD, AR | |
ELOVL1 | 847 | NM_001256399.2 | AD | |
ELOVL4 | 945 | NM_022726.4 | AD | |
ENPP1 | 2778 | NM_006208.3 | AD | |
GJA1 | 1149 | NM_000165.5 | AD | |
JUP | 2238 | NM_002230.4 | AR | |
KDSR | 999 | NM_002035.4 | AR | |
KRT14 | 1419 | NM_000526.5 | AD | |
KRT16 | 1422 | NM_005557.4 | AD | |
KRT17 | 1299 | NM_000422.3 | AD, AR | |
KRT9 | 1872 | NM_000226.4 | AD | |
MPDU1 | 744 | NM_004870.4 | AR | |
MSMO1 | 489 | NM_001017369.3 | AR | |
NSDHL | 1122 | NM_015922.3 | XL | |
PEX7 | 972 | NM_000288.4 | AR | |
PIGL | 759 | NM_004278.4 | AR | |
RHBDF2 | 2484 | NM_001005498.4 | AD | |
RSPO1 | 792 | NM_001038633.4 | AR | |
SDR9C7 | 946 | NM_148897.3 | AR | |
SERPINB7 | 1143 | NM_001040147.3 | AR | |
SLC27A4 | 1932 | NM_005094.4 | AR | |
SLURP1 | 312 | NM_020427.3 | AR | |
SMARCAD1 | 3087 | NM_001128429.3 | AD | |
SRD5A3 | 957 | NM_024592.5 | AR | |
SREBF1 | 3534 | NM_001005291.3 | AD | |
SULT2B1 | 1053 | NM_004605.2 | AR | |
TAT | 1365 | NM_000353.3 | AR | |
TGM5 | 2163 | NM_201631.4 | AR | |
TRPV3 | 2376 | NM_001258205.2 | AD |
Informations about the disease
Ichthyoses are generalized dermatoses characterized by varying degrees of scaling, hyperkeratosis as well as erythroderma. They are often associated with palmoplantar keratoderma (PPK) or hyperlinearity. These keratinization disorders may be genetic or acquired. Hereditary ichthyosis is divided into syndromal and non-syndromal forms. In congenital ichthyoses, skin symptoms present either as collodion membrane or congenital ichthyosiform erythroderma. Collodion babies later develop lamellar ichthyosis or rarer variants such as improving collodion ichthyosis. The latter includes the rare autosomal recessive congenital ichthyosis, which manifests clinically as, for example, harlequin ichthyosis. In the common ichthyoses such as ichthyosis vulgaris, skin symptoms usually do not appear until several weeks to months after birth. Ichthyoses caused by keratin mutations, such as epidermolytic ichthyosis, superficial epidermolytic ichthyosis and congenital reticular ichthyosiform erythroderma, are called keratinopathic ichthyoses. They often manifest with blistering at birth. The PPKs also include a heterogeneous group of disorders characterized by persistent epidermal thickening of the palms and soles, such as diffuse hereditary PPK, focal and striatal hereditary PPK, and punctate hereditary PPK. In these two large groups of cornification disorders, all classical inheritance patterns are observed. The DNA diagnostic yield appears to be between 50-80%, largely depending on the given clinical workup of the patient group. Therefore, a negative result does not exclude the clinical dermatological diagnosis.
References: https://www.ncbi.nlm.nih.gov/books/NBK1420/
https://www.medicaljournals.se/acta/content/html/10.2340/00015555-3432
https://www.ncbi.nlm.nih.gov/books/NBK562318/
https://emedicine.medscape.com/article/1108406-overview
- Allelic: CK syndrome (NSDHL)
- Allelic: Cardiomyopathy, dilated, with woolly hair + keratoderma (DSP)
- Allelic: Chondrodysplasia punctata, XLD (EBP)
- Allelic: Dilated cardiomyopathy with woolly hair, keratoderma + tooth agenesis (DSP)
- Allelic: Peeling skin syndrome 1 (CDSN)
- Allelic: Proteasome-associated autoinflammatory syndrome 2 (POMP)
- Allelic: Psoriasis 2 (CARD14)
- Allelic: Spinocerebellar ataxia 34 (ELOVL4)
- Allelic: Stargardt disease 3 (ELOVL4)
- Allelic: Xeroderma pigmentosum, group B (ERCC3)
- Allelic: Xeroderma pigmentosum, group D (ERCC2)
- Adermatoglyphia (SMARCAD1)
- Allelic: Lewy body dementia, susceptibility to (GBA1)
- Allelic: Parkinson disease, late-onset, susceptibility to (GBA1)
- Arrhythmogenic right ventricular dysplasia 11 with mild palmoplantar keratod. + woolly hair (DSC2)
- Arthrogryposis, renal dysfunction + cholestasis 1 (VPS33B)
- Basan syndrome (SMARCAD1)
- CHILD syndrome (NSDHL)
- CHIME syndrome (PIGL)
- Cerebral dysgenesis, neuropathy, ichthyosis, and palmoplantar keratoderma syndrome (SNAP29)
- Chanarin-Dorfman syndrome (ABHHD5)
- Cole disease (ENPP)
- Congenital disorder of glycosylation, type If (MPDU1)
- Congenital disorder of glycosylation, type Im (DOLK)
- Congenital disorder of glycosylation, type Iq (SRD5A3)
- Dermatopathia pigmentosa reticularis (KRT14)
- Ectodermal dysplasia 2, Clouston type (GJB6)
- Epidermolysis bullosa simplex, Dowling-Meara type (KRT14)
- Epidermolysis bullosa simplex, Koebner type (KRT14)
- Epidermolysis bullosa simplex, Weber-Cockayne type (KRT14)
- Epidermolysis bullosa simplex, recessive 1 (KRT14)
- Epidermolysis bullosa, lethal acantholytic (DSP)
- Epidermolytic hyperkeratosis (KRT1)
- Epidermolytic hyperkeratosis (KRT10)
- Erythroderma, congenital, with palmoplantar keratoderma, hypotrichosis + hyper IgE (DSG1)
- Erythrokeratodermia variabilis et progressiva 1 (GJB3)
- Erythrokeratodermia variabilis et progressiva 2 (GJB4)
- Erythrokeratodermia variabilis et progressiva 3 (GJA1)
- Erythrokeratodermia variabilis et progressiva 4 (KDSR)
- Erythrokeratodermia variabilis et progressiva 5 (KRT83)
- Erythrokeratodermia variabilis et progressiva 7 (PERP)
- Gaucher disease, perinatal lethal (GBA1)
- Gaucher disease, type I, II, III, IIIC (GBA1)
- HELIX syndr.: Hypohidrosis, Electrolyte imbal., Lacrimal gland dysf., Ichthyosis, Xerostomy (CLDN10)
- Huriez syndrome (SMARCAD1)
- IFAP syndrome with or without BRESHECK syndrome (MBTPS2)
- Ichthyosis bullosa of Siemens (KRT2)
- Ichthyosis histrix, Curth-Macklin type (KRT1)
- Ichthyosis prematurity syndrome (SLC27A4)
- Ichthyosis vulgaris (FLG)
- Ichthyosis with confetti (KRT10)
- Ichthyosis, XL (STS)
- Ichthyosis, congenital, AR 1 (TGM1)
- Ichthyosis, congenital, AR 10 (PNPLA1)
- Ichthyosis, congenital, AR 11 (ST14)
- Ichthyosis, congenital, AR 12 (CASP14)
- Ichthyosis, congenital, AR 14 (SULT2B1)
- Ichthyosis, congenital, AR 2 (ALOX12B)
- Ichthyosis, congenital, AR 3 (ALOXE3)
- Ichthyosis, congenital, AR 4A, 4B [harlequin] (ABCA12)
- Ichthyosis, congenital, AR 5 (CYP4F22)
- Ichthyosis, congenital, AR 6 (NIPAL4)
- Ichthyosis, congenital, AR 8 (LIPN)
- Ichthyosis, congenital, AR 9 (CERS3)
- Ichthyosis, congenital, Ar 13 (SDR9C7)
- Ichthyosis, cyclic, with epidermolytic hyperkeratosis (KRT1)
- Ichthyosis, cyclic, with epidermolytic hyperkeratosis (KRT10)
- Ichthyosis, follicular, with atrichia + photophobia syndrome 2 (SREBF1)
- Ichthyosis, lamellar, AD (ASPRV1)
- Ichthyosis, leukocyte vacuoles, alopecia + sclerosing cholangitis (CLDN1)
- Ichthyosis, spastic quadriplegia + mental retardation (ELOVL4)
- Ichthyotic keratoderma, spasticity, hypomyelination + dysmorphic facies (ELOVL1)
- Kahrizi syndrome (SRD5A3)
- Keratitis-ichthyosis-deafness syndrome (GJB2)
- Keratoderma, palmoplantar, punctate type IA (AAGAB)
- Keratoderma, palmoplantar, with deafness (GJB2)
- Keratosis follicularis spinulosa decalvans, XL (MBTPS2)
- Keratosis linearis with ichthyosis congenita + sclerosing keratoderma (POMP)
- Keratosis palmoplantaris striata I, AD (DSG1)
- Keratosis palmoplantaris striata II (DSP)
- Keratosis palmoplantaris striata III (KRT1)
- MEDNIK syndrome (AP1S1)
- MEND syndrome (EBP)
- Meleda disease (SLURP1)
- Microcephaly, congenital cataract + psoriasiform dermatitis (MSMO1)
- Monilethrix (KRT83)
- Mucoepithelial dysplasia, hereditary (SREBF1)
- Multiple sulfatase deficiency (SUMF1)
- Naegeli-Franceschetti-Jadassohn syndrome (KRT14)
- Naxos disease (JUP)
- Netherton syndrome (SPINK5)
- Olmsted syndrome 1 (TRPV3)
- Olmsted syndrome 2 (PERP)
- Olmsted syndrome, XL (MBTPS2)
- Pachyonychia congenita 1 (KRT16)
- Pachyonychia congenita 2 (KRT17)
- Pachyonychia congenita 3 (KRT6A)
- Pachyonychia congenita 4 (KRT6B)
- Palmoplantar hyperkeratosis and true hermaphroditism (RSPO1)
- Palmoplantar hyperkeratosis with squamous cell carcinoma of skin + sex reversal (RSPO1)
- Palmoplantar keratoderma with congenital alopecia (GJA1)
- Palmoplantar keratoderma, Bothnian type (AQP5)
- Palmoplantar keratoderma, Nagashima type (SERPINB7)
- Palmoplantar keratoderma, epidermolytic (KRT1)
- Palmoplantar keratoderma, epidermolytic (KRT9)
- Palmoplantar keratoderma, nonepidermolytic (KRT1)
- Palmoplantar keratoderma, nonepidermolytic, focal (KRT16)
- Palmoplantar keratoderma, nonepidermolytic, focal 2 (TRPV3)
- Palmoplantar keratoderma, nonepidermolytic, focal or diffuse (KRT6C)
- Peeling skin syndrome 2 (TGM5)
- Peeling skin syndrome 3 (CHST8)
- Peeling skin syndrome 4 (CSTA)
- Peeling skin syndrome 5 (SERPINB8)
- Peeling skin syndrome 6 (FLG2)
- Peeling skin with leukonychia, acral punctate keratoses, cheilitis + knuckle pads (CAST)
- Peroxisome biogenesis disorder 9B (PEX7)
- Pityriasis rubra pilaris (CARD14)
- Refsum disease (PHYH)
- Rhizomelic chondrodysplasia punctata, type 1 (PEX7)
- Sjogren-Larsson syndrome (ALDH3A2)
- Sjogren-Larsson syndrome (ALH3A2)
- Skin fragility-woolly hair syndrome (DSP)
- Steatocystoma multiplex (KRT17)
- Trichothiodystrophy 1, photosensitive (ERCC2)
- Trichothiodystrophy 2, photosensitive (ERCC3)
- Trichothiodystrophy 3, photosensitive (GTF2H5)
- Trichothiodystrophy 4, nonphotosensitive (MPLKIP)
- Trichothiodystrophy 5, nonphotosensitive (RNF113A)
- Trichothiodystrophy 6, nonphotosensitive (GTF2E2)
- Tylosis with esophageal cancer (RHBDF2)
- Tyrosinemia, type II (TAT)
- Vohwinkel syndrome with ichthyosis (LORICRIN)
- Weill-Marchesani 4 syndrome, AR (ADAMTS17)
- AD
- AR
- XL
- XLR
- digenisch
- Multiple OMIM-Ps
Bioinformatics and clinical interpretation
Test-Stärken
- DAkkS-akkreditiertes Labor
- EU-Richtlinie für IVD in Umsetzung
- Qualitäts-kontrolliert arbeitendes Personal
- Leistungsstarke Sequenzierungstechnologien, fortschrittliche Target-Anreicherungsmethoden und Präzisions-Bioinformatik-Pipelines sorgen für überragende analytische Leistung
- Sorgfältige Kuratierung klinisch relevanter und wissenschaftlich begründeter Gen-Panels
- eine Vielzahl nicht Protein-kodierender Varianten, die in unseren klinischen NGS-Tests mit erfasst werden
- unser strenges Variantenklassifizierungsschema nach ACMG-Kriterien
- unser systematischer klinischer Interpretations-Workflow mit proprietärer Software ermöglicht die genaue und nachvollziehbare Verarbeitung von NGS-Daten
- unsere umfassenden klinischen Aussagen
Testeinschränkungen
- Gene mit eingeschränkter Abdeckung werden gekennzeichnet
- Gene mit kompletten oder partiellen Duplikationen werden gekennzeichnet
- es wird angenommen, dass ein Gen suboptimal abgedeckt ist, wenn >90% der Nukleotide des Gens bei einem Mapping-Qualitätsfaktor von >20 (MQ>20) nicht abgedeckt sind
- die Sensitivität der Diagnostik zur Erkennung von Varianten mit genannten Testeinschränkungen ist möglicherweise begrenzt bei:
- Gen-Konversionen
- komplexe Inversionen
- Balancierte Translokationen
- Mitochondriale Varianten
- Repeat-Expansionen, sofern nicht anders dokumentiert
- nicht kodierende Varianten, die Krankheiten verursachen, die von diesem Panel nicht mit abgedeckt werden
- niedriger Mosaik-Status
- Repeat-Blöcke von Mononukleotiden
- Indels >50bp (Insertionen-Deletionen)
- Deletionen oder Duplikationen einzelner Exons
- Varianten innerhalb von Pseudogenen
- die analytische Sensitivität kann geringer ausfallen werden, wenn die DNA nicht von amedes genetics extrahiert wurde
Laboratory requirement
Die in grün gezeigten Gene sind kuratiert und werden als Gen-Panel untersucht. Eine Erweiterung des Panels (blau gezeigte Gene, jeweils ebenfalls kuratiert) kann auf Anfrage erfolgen. Sofern unter "Erweitertes Panel" ein Minuszeichen angezeigt wird, sind nur Core-/Basis-Gene verfügbar.
Für die Anforderung einer genetischen Untersuchung senden Sie uns bitte die Krankheits-ID auf einem Überweisungsschein. Bitte die Material-Angabe beachten.
Für privat versicherte Patienten empfehlen wir einen Antrag auf Kostenübernahme bei der Krankenversicherung.
Die Untersuchung wird auch für Selbstzahler angeboten.